Renovaro Biosciences Inc. (RENB) NASDAQ

0.35

+0.0246(+7.61%)

Updated at May 13 01:16PM

Currency In USD

Valuation

Market Cap150.15M
Enterprise Value153.71M
P/E Ratio-0.67
PEG Ratio-0.15
Price/Sales Ratio311.62
Price/Book Ratio0.69
Enterprise/Revenue344.99
Enterprise/EBITDA-0.41

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-464.14
Operating Margin-508.01

Management Effectiveness

Return On Assets-0.76
Return On Equity-0.7

Income Statement

Revenue0
Revenue/Share0
Gross Profit-121,859
EBITDA-81.52M
Net Income-80.65M
Diluted EPS-0.84

Balance Sheet

Total Cash311,764
Total Cash/Share0
Total Debt6.37M
Total Debt/Equity0.08
Current Ratio0.06
Book Value Per Share0.51

Price History

52-Week Change-69.98
52-Week High2.34
52-Week Low0.28
Moving Average 50 Days0.58
Moving Average 200 Days0.73

Statistics

Average Volume1.21M
Shares Outstanding162.39M
% Held by Institutions14.13

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A